Clinical Trials Logo

Cerebral Palsy clinical trials

View clinical trials related to Cerebral Palsy.

Filter by:

NCT ID: NCT03122171 Completed - Cerebral Palsy Clinical Trials

Use of Low Cost Prostheses to Improve Upper Extremity Function in Children With Cerebral Palsy

Start date: April 1, 2017
Phase: N/A
Study type: Interventional

The purpose of the study is to assess the effectiveness of an upper extremity prosthesis in improving the upper extremity function of children with cerebral palsy who have limited use of their hands. Twelve children, aged 4-17 years, who have cerebral palsy and limitations in their ability to use their hands, will be enrolled. All participants will be fitted with a 3D printed arm/hand prosthesis and receive 8 occupational therapy sessions. Each subject will be evaluated pre-treatment, post-occupational therapy sessions and at 6 months follow-up. The evaluation will include assessment of (1)passive and active arm/hand movement and (2)functional hand skills using several standardized tests. The results from the pre-treatment and the two post-treatment evaluations will be compared.

NCT ID: NCT03121651 Completed - Cerebral Palsy Clinical Trials

Medication Management Among Individuals With Neurodevelopmental Disabilities

M-MIND
Start date: November 11, 2016
Phase: N/A
Study type: Interventional

This is a pilot study to develop a reinforcement learning (RL)-adaptive visual and interactive support application (hereafter RL-adaptive support) to help young adults with spina bifida or cerebral palsy become more independent with medication management. Individuals with disabilities who are empowered to manage several aspects of their lives can ultimately be better integrated into and contribute more to society.

NCT ID: NCT03117322 Completed - Cerebral Palsy Clinical Trials

Synbiotic, Prebiotics and Probiotics in Children With Cerebral Palsy and Constipation

Start date: June 5, 2017
Phase: Phase 4
Study type: Interventional

Randomized double blind controlled clinical trial. Participants will be enrolled at the New Civil Hospital of Guadalajara "Dr. Juan I. Menchaca" during the period from May 2017 to July 2018, from six to 59 months of either sex. The duration of each participant in the study will be of four weeks. Each participant will be randomized assigned to any of the different study groups: synbiotic, prebiotic, probiotic or placebo. Hypothesis: The efficacy of supplementation with a symbiotic, a prebiotic and a probiotic differs in its beneficial effect on the intestinal microbiota and the characteristics of feces in children with CP and chronic constipation.

NCT ID: NCT03112434 Completed - Clinical trials for Unilateral Spastic Cerebral Palsy

Muscle Elastography in Spastic Cerebral Palsy

Start date: December 14, 2017
Phase:
Study type: Observational

To date, clinical tests are unable to differentiate between the cause of muscle stiffness, although a manual instrumented spasticity assessment for the lower limb that utilizes surface electromyogram has recently been proposed. This study intends to use shear wave elastography to assess individual muscle stiffness parameters and the individual response to botulinum toxin injection in the elbow and wrist flexors. Collection of baseline spasticity parameters could then be used to predict the effect of botulinum toxin type A and ultimately serve as a basis for development of a treatment model for muscle spasticity in patients with spastic cerebral palsy.

NCT ID: NCT03110341 Recruiting - Cerebral Palsy Clinical Trials

Effect of Erythropoietin in Premature Infants on White Matter Lesions and Neurodevelopmental Outcome

Start date: April 10, 2017
Phase: Phase 3
Study type: Interventional

Preterm and very preterm infants are at risk of developing encephalopathy of prematurity and long-term neurodevelopmental delay. Magnetic resonance imaging (MRI) allows the characterization of specific features of encephalopathy of prematurity, including structural changes of brain white matter and gray matter. This study wants to investigate important evidence that early repeated high-dose rhEPO(5250 IU/kg) treatment improves long-term neurological outcomes in very preterm infants and without obvious adverse effects.

NCT ID: NCT03107975 Enrolling by invitation - Clinical trials for Spastic Cerebral Palsy

Effect of Human Amniotic Epithelial Cells on Children With Spastic Cerebral Palsy

Start date: April 1, 2017
Phase: Phase 1
Study type: Interventional

This study aimed to evaluate the therapeutic potential of human amniotic epithelial cell (hAEC) transplant in the management of children with spastic cerebral palsy.

NCT ID: NCT03099993 Completed - Clinical trials for Unilateral Cerebral Palsy

Sensitivity of an Upper Limb Motion Analysis Protocol to Changes in Kinematics and Muscle Activity After Constraint Induced Therapy in Children With Hemiplegia

MouvsupTCIHemi
Start date: March 28, 2017
Phase: N/A
Study type: Interventional

In France, Cerebral Palsy (CP) affects 1 in 450 births. It results from lesions of the brain, before, during, or shortly after birth. These non-progressive lesions cause muscle impairments, responsible for activity limitations. These muscle impairments include muscle stiffness, and muscle weakness. Children with Unilateral CP (UCP) have these impairments on only one side of the body. To compensate for activity limitations with their impaired arm, these children over-use their non-impaired arm. The objective of constraint-induced therapy (CIT) is to minimize this asymmetry which deteriorates mobility on the impaired side, by forcing the child to only use its impaired arm several hours a day during several weeks of therapy. It is known using clinical tests that this therapy improves the overall motor function of the impaired arm. However, the underlying mechanisms are yet unknown. An understanding of these mechanisms would suggest ways to maximize the effectiveness of this therapy, which requires a significant commitment from the child and its family. The investigaors propose in this project a quantitative and objective evaluation of the effect of CIT on the movements of the impaired arm of children with UCP. The investogators focus their analysis on muscle activation, to assess which aspect of muscle impairments is modified by CIT. To this end, the investigators will use sensors identical to those already used in clinics for the Quantified Gait Analysis of children with CP, recognized since 2006 by the Haute Autorité de Santé as providing key supplementary data in the evaluation of complex gait disorders. Results from this study will provide leads to optimize CIT. Some children could for example benefit from CIT paired with treatments to reduce muscle stiffness or to strengthen muscles

NCT ID: NCT03094455 Completed - Hemiplegia Clinical Trials

AOT and ICT for Hemiplegia

Tele-UPCAT
Start date: March 29, 2017
Phase: N/A
Study type: Interventional

A new rehabilitative approach, called AOT, based on the recent discovery of mirror neuron system (MNS), has been used with promising results on the Upper Limb (UL) function in some studies in children with Cerebral Palsy (CP).The purpose of the present trial is to provide evidence by a RCT that AOT is an effective rehabilitation tool in Children with Unilateral CP (UCP) and that its effects are greater than standard care. Assisting Hand Assessment is chosen as primary outcome measure and a sample size of 10 per group is required. The rehabilitation lasting 3 weeks will be provided at home by an ICT platform able to deliver, manage, monitor and measure a personalized AOT.

NCT ID: NCT03087110 Completed - Cerebral Palsy Clinical Trials

Stem Cells in Umbilical Blood Infusion for CP

SCUBI-CP
Start date: March 2016
Phase: Phase 1
Study type: Interventional

This study will investigate the safety of single dose intravenous infusion of cord blood cells which were cryopreserved after the birth of a brother or sister to a child with cerebral palsy.

NCT ID: NCT03079362 Completed - Cerebral Palsy Clinical Trials

SDR Monitoring in Children With Cerebral Palsy

Start date: January 15, 2007
Phase: N/A
Study type: Observational

The study evaluates the anatomical distribution of the assessed Electromyogram (EMG) responses ensuring after sensory nerve root stimulation and obtained IOM grading during selective dorsal rhizotomy (SDR) with regard to level and, side of the body and gender as well as pain management and outcome data.